Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases

키워드

참고문헌 (94)

1. Salem RM, "New attention to the IUD : expanding women’s contraceptive options to meet their needs", Popul Rep B, pp.1~26 (2006)
2. (2013)[URL]
3. Perino A, "Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices", Acta Eur Fertil, 18, pp.137~140 (1987)
4. Inki P, "Long-term use of the levonorgestrel-releasing intrauterine system", Contraception, 75, pp.S161~S166 (2007)
5. Heikinheimo O, "Emerging indications for the levonorgestrel-releasing intrauterine system(LNG-IUS)", Acta Obstet Gynecol Scand, 91, pp.3~9 (2012)
6. Hurskainen R, "Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up", JAMA, 291, pp.1456~1463 (2004)
7. Lethaby AE, "Progesterone or progestogen- releasing intrauterine systems for heavy menstrual bleeding", Cochrane Database Syst Rev, (4), pp.CD002126~ (2005)
8. Gupta J, "Levonorgestrel intrauterine system versus medical therapy for menorrhagia", N Engl J Med, 368, pp.128~137 (2013)
9. ESHRE Capri Workshop Group, "Intrauterine devices and intrauterine systems", Hum Reprod Update, 14, pp.197~208 (2008)
10. Espey E, "Levonorgestrel intrauterine system : first-line therapy for heavy menstrual bleeding", N Engl J Med, 368, pp.184~185 (2013)
11. Gruppo italiano per lo studio dell’endometriosi, "Prevalence and anatomical distribution of endometriosis in women with selected gynaecological conditions: results from a multicentric Italian study", Hum Reprod, 9, pp.1158~1162 (1994)
12. Ajossa S, "The prevalence of endometriosis in premenopausal women undergoing gynecological surgery", Clin Exp Obstet Gynecol, 21, pp.195~197 (1994)
13. Evers JL, "Is there a solution for recurrent endometriosis?", Br J Clin Pract Suppl, 72, pp.45~50 (1991)
14. Guo SW, "Recurrence of endometriosis and its control", Hum Reprod Update, 15, pp.441~461 (2009)
15. Cheong Y, "Laparoscopic surgery for endometriosis: how often do we need to re-operate?", J Obstet Gynaecol, 28, pp.82~85 (2008)
16. Park HJ, "Postoperative long-term maintenance therapy with oral contraceptives after gonadotropin-releasing hormone analog treatment in women with ovarian endometrioma", J Minim Invasive Gynecol, 16, pp.34~39 (2009)
17. Prentice A, "Gonadotrophin-releasing hormone analogues for pain associated with endometriosis", Cochrane Database Syst Rev, (2), pp.CD000346~ (2000)
18. Yap C, "Pre and post operative medical therapy for endometriosis surgery", Cochrane Database Syst Rev, (3), pp.CD003678~ (2004)
19. Abou-Setta AM, "Levonorgestrel- releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery", Cochrane Database Syst Rev, (4), pp.CD005072~ (2006)
20. Parazzini F, "Postsurgical medical treatment of advanced endometriosis: results of a randomized clinical trial", Am J Obstet Gynecol, 171, pp.1205~1207 (1994)
21. Busacca M, "Post-operative GnRH analogue treatment after conservative surgery for symptomatic endometriosis stage III-IV: a randomized controlled trial", Hum Reprod, 16, pp.2399~2402 (2001)
22. Nilsson CG, "Endometrial morphology of women using a d-norgestrel-releasing intrauterine device", Fertil Steril, 29, pp.397~401 (1978)
23. Hurskainen R, "Expression of sex steroid receptors and Ki-67 in the endometria of menorrhagic women : effects of intrauterine levonorgestrel", Mol Hum Reprod, 6, pp.1013~1018 (2000)
24. Luukkainen T, "The levonorgestrel intrauterine system : therapeutic aspects", Steroids, 65, pp.699~702 (2000)
25. Maruo T, "Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium", Hum Reprod, 16, pp.2103~2108 (2001)
26. Ramey JW, "Peritoneal fluid: its relevance to the development of endometriosis", Fertil Steril, 60, pp.1~14 (1993)
27. Kupker W, "Paracrine changes in the peritoneal environment of women with endometriosis", Hum Reprod Update, 4, pp.719~723 (1998)
28. McLaren J, "Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids", J Clin Invest, 98, pp.482~489 (1996)
29. Vercellini P, "A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis : a pilot study", Fertil Steril, 72, pp.505~508 (1999)
30. Vercellini P, "Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis : a pilot study", Fertil Steril, 80, pp.305~309 (2003)
31. Tanmahasamut P, "Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain : a randomized controlled trial", Obstet Gynecol, 119, pp.519~526 (2012)
32. Petta CA, "Randomized clinical trial of a levonorgestrel- releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis", Hum Reprod, 20, pp.1993~1998 (2005)
33. Bayoglu Tekin Y, "Postoperative medical treatment of chronic pelvic pain related to severe endometriosis : levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue", Fertil Steril, 95, pp.492~496 (2011)
34. Kjerulff KH, "Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis", J Reprod Med, 41, pp.483~490 (1996)
35. Stewart EA, "Uterine fibroids", Lancet, 357, pp.293~298 (2001)
36. Magalhaes J, "Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas", Contraception, 75, pp.193~198 (2007)
37. Soysal S, "The efficacy of levonorgestrel-releasing intrauterine device in selected cases of myoma-related menorrhagia : a prospective controlled trial", Gynecol Obstet Invest, 59, pp.29~35 (2005)
38. Grigorieva V, "Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas", Fertil Steril, 79, pp.1194~1198 (2003)
39. Mercorio F, "The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia", Contraception, 67, pp.277~280 (2003)
40. Gunes M, "The effect of levonorgestrel intrauterine system on uterine myomas : a 1-year follow-up study", J Minim Invasive Gynecol, 15, pp.735~738 (2008)
41. Murat Naki M, "Levonorgestrel-releasing intrauterine device insertion ameliorates leiomyoma-dependent menorrhagia among women of reproductive age without a significant regression in the uterine and leiomyoma volumes", Fertil Steril, 94, pp.371~374 (2010)
42. Sivin I, "Health during prolonged use of levonorgestrel 20 micrograms", d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study, 1994, pp.61, 70~77
43. Kriplani A, "Efficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyoma", Int J Gynaecol Obstet, 116, pp.35~38 (2012)
44. Backman T, "Advance information improves user satisfaction with the levonorgestrel intrauterine system", Obstet Gynecol, 99, pp.608~613 (2002)
45. Ikomi A, "Treatment of menorrhagia with the levonorgestrel intrauterine system: can we learn from our failures?", J Obstet Gynaecol, 20, pp.630~631 (2000)
46. Rosa e Silva JC, "Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas", J Reprod Med, 50, pp.613~617 (2005)
47. Rabinovici J, "New interventional techniques for adenomyosis", Best Pract Res Clin Obstet Gynaecol, 20, pp.617~636 (2006)
48. Takebayashi T, "Danazol suspension injected into the uterine cervix of patients with adenomyosis and myoma : preliminary study", Gynecol Obstet Invest, 39, pp.207~211 (1995)
49. Nelson JR, "Long-term management of adenomyosis with a gonadotropin-releasing hormone agonist : a case report", Fertil Steril, 59, pp.441~443 (1993)
50. Fedele L, "Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device", Fertil Steril, 68, pp.426~429 (1997)
51. Wood C, "Surgical and medical treatment of adenomyosis", Hum Reprod Update, 4, pp.323~336 (1998)
52. Benagiano G, "Adenomyosis: new knowledge is generating new treatment strategies", Womens Health (Lond Engl), 5, pp.297~311 (2009)
53. Phillips DR, "Endometrial ablation for postmenopausal uterine bleeding induced by hormone replacement therapy", J Am Assoc Gynecol Laparosc, 2, pp.389~393 (1995)
54. Englander MJ, "Uterine artery embolization for the treatment of adenomyosis", Semin Intervent Radiol, 25, pp.387~393 (2008)
55. Yoon SW, "Successful use of magnetic resonance-guided focused ultrasound surgery to relieve symptoms in a patient with symptomatic focal adenomyosis", Fertil Steril, 90, pp.2018.e13~2018.e15 (2008)
56. Bragheto AM, "Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging", Contraception, 76, pp.195~199 (2007)
57. Cho S, "Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis", Am J Obstet Gynecol, 198, pp.373.e1~373.e7 (2008)
58. Sheng J, "The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis", Contraception, 79, pp.189~193 (2009)
59. Ozdegirmenci O, "Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis", Fertil Steril, 95, pp.497~502 (2011)
60. Whiteman MK, "Use of contraceptive methods among women with endometrial hyperplasia: a systematic review", Contraception, 82, pp.56~63 (2010)
61. Kurman RJ, "The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients", Cancer, 56, pp.403~412 (1985)
62. Tabata T, "Natural history of endometrial hyperplasia. Study of 77 patients", Arch Gynecol Obstet, 265, pp.85~88 (2001)
63. Trimble CL, "Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study", Cancer, 106, pp.812~819 (2006)
64. Clark TJ, "The management of endometrial hyperplasia : an evaluation of current practice", Eur J Obstet Gynecol Reprod Biol, 125, pp.259~264 (2006)
65. Trimble CL, "Management of endometrial precancers", Obstet Gynecol, 120, pp.1160~1175 (2012)
66. Marsden DE, "Optimal management of endometrial hyperplasia", Best Pract Res Clin Obstet Gynaecol, 15, pp.393~405 (2001)
67. Wildemeersch D, "Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system : long-term follow-up", Maturitas, 57, pp.210~213 (2007)
68. Orbo A, "Treatment results of endometrial hyperplasia after prospective D-score classification : a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only", Gynecol Oncol, 111, pp.68~73 (2008)
69. Varma R, "The effectiveness of a levonorgestrel-releasing intrauterine system(LNG-IUS)in the treatment of endometrial hyperplasia--a long-term follow-up study", Eur J Obstet Gynecol Reprod Biol, 139, pp.169~175 (2008)
70. Vereide AB, "Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia", Gynecol Oncol, 101, pp.214~223 (2006)
71. Vereide AB, "Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia : a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone", Gynecol Oncol, 91, pp.526~533 (2003)
72. Gallos ID, "Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis", Am J Obstet Gynecol, 203, pp.547.e1~547.e10 (2010)
73. 이서영, "The effectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women", Journal of Gynecologic Oncology, 21(2), pp.102~105 (2010), 대한부인종양학회
74. Lee TS, "Management of endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: single arm, prospective multicenter study: Korean gynecologic oncology group study (KGOG2006)", Jpn J Clin Oncol, 41, pp.817~819 (2011)
75. "Surveillance epidemiology and end results. SEER Stat fact sheets: corpus and uterus"[URL]
76. Elit L, "Current status and future innovations of hormonal agents, chemotherapy and investigational agents in endometrial cancer", Curr Opin Obstet Gynecol, 14, pp.67~73 (2002)
77. Gallup DG, "Adenocarcinoma of the endometrium in women 40 years of age or younger", Obstet Gynecol, 64, pp.417~420 (1984)
78. Soliman PT, "Risk factors for young premenopausal women with endometrial cancer", Obstet Gynecol, 105, pp.575~580 (2005)
79. Creasman WT, "Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer", Int J Gynaecol Obstet, 95(Suppl 1), pp.S105~S143 (2006)
80. Benshushan A, "Endometrial adenocarcinoma in young patients: evaluation and fertility-preserving treatment", Eur J Obstet Gynecol Reprod Biol, 117, pp.132~137 (2004)
81. Rose PG, "Endometrial carcinoma", N Engl J Med, 335, pp.640~649 (1996)
82. Creasman WT, "Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study", Cancer, 60, pp.2035~2041 (1987)
83. Leitao MM, "Advances in the management of endometrial carcinoma", Gynecol Oncol, 120, pp.489~492 (2011)
84. Randall TC, "Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40", Obstet Gynecol, 90, pp.434~440 (1997)
85. Ramirez PT, "Hormonal therapy for the management of grade 1 endometrial adenocarcinoma : a literature review", Gynecol Oncol, 95, pp.133~138 (2004)
86. Kim YB, "Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature", Cancer, 79, pp.320~327 (1997)
87. Kaku T, "Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome", Cancer Lett, 167, pp.39~48 (2001)
88. Gotlieb WH, "Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer", Obstet Gynecol, 102, pp.718~725 (2003)
89. Saegusa M, "Progesterone therapy for endometrial carcinoma reduces cell proliferation but does not alter apoptosis", Cancer, 83, pp.111~121 (1998)
90. Gallos ID, "Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis", Am J Obstet Gynecol, 207, pp.266.e1~266.e12 (2012)
91. Montz FJ, "Intrauterine progesterone treatment of early endometrial cancer", Am J Obstet Gynecol, 186, pp.651~657 (2002)
92. Cade TJ, "Progestogen treatment options for early endometrial cancer", BJOG, 117, pp.879~884 (2010)
93. Kim MK, "Conservative treatment with medroxyprogesterone acetate plus levonorgestrel intrauterine system for early-stage endometrial cancer in young women : pilot study", Int J Gynecol Cancer, 21, pp.673~677 (2011)
94. Kim MK, "Treatment with medroxyprogesterone acetate plus levonorgestrel-releasing intrauterine system for early-stage endometrial cancer in young women: single-arm, prospective multicenter study: Korean gynecologic oncology group study (KGOG2009)", Jpn J Clin Oncol, 42, pp.1215~1218 (2012)

관련 논문AI추천